The success of a peritoneal dialysis (PD) program depends on a multitude of factors that are interlinked and inseparable from one another. Each program needs to identify its special circumstances, deficiencies, and strong points, and then to strategize accordingly. Ultimately, “teamwork” is the mantra for a successful outcome, the patient being central to all endeavors. A belief and a passion for PD are the fountainhead and cornerstone on which to build a quality PD program.
PopovichRPMoncriefJWDecherdJFBomarJBPyleWK. The definition of a novel portable/wearable equilibrium dialysis technique [Abstract]. Trans Am Soc Artif Intern Organs1976; 5:64.
2.
PopovichRPMoncriefJW. Kinetic modeling of peritoneal transport. Contrib Nephrol1979; 17:59–72.
KawaguchiY.Socioeconomic aspects of peritoneal dialysis: role of non-medical factors in chronic dialysis—dialysis in Asia, regional differences. Perit Dial Int1999; 19(Suppl 2):S423–6.
5.
MahajanSTiwariSCKalraVBhowmikDMAgarwalSK. Factors affecting the use of peritoneal dialysis among the ESRD population in India: a single-center study. Perit Dial Int2004; 24:538–41.
6.
SahaDAgarwalSK. Hepatitis and HIV infection during haemodialysis. J Indian Med Assoc2001; 99:194–9, 203,213.
7.
AgarwalSKDashSCIrshadM.Hepatitis C virus infection during haemodialysis in India. J Assoc Physicians India1999; 47:1139–43.
8.
PujolFHPonceJGLemaMGCaprilesFDevesaMSiritF. High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence. J Clin Microbiol1996; 34:1633–6.
9.
TaduriGMurtyKVPillalamarriNPLakshmiM.Avoidance of hepatitis C transmission: a major advantage for PD in an Indian center. Perit Dial Int2005; 25:605–6.
10.
WadhwaNKSuhHCabraldaTSokolESokunbiDSolomonM.Peritonealdialysis with trained home nurses in elderly and disabled end-stage renal disease patients. Adv Perit Dial1993; 9:130–3.
11.
SubhramanyamSVSinojKAMaryBNayakKS. Our experience with new connectology for CAPD [Abstract]. Perit Dial Int2005; 25(Suppl 2):S22.
12.
LiPKLawMCChowKMChanWKSzetoCCChengYL. Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis: a prospective, randomized, controlled, multicenter study. Am J Kidney Dis2002; 40:373–80.
13.
PaniaguaRAmatoDVoneshECorrea-RotterRRamosAMoranJ. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol2002; 13:1307–20.
14.
LoWKHoYWLiCSWongKSChanTMYuAW. Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int2003; 64:649–56.
15.
StruijkDGKredietRT. European best practice guidelines: adequacy in peritoneal dialysis. Contrib Nephrol2003; 140:170–5.
16.
NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy.Am J Kidney Dis2001; 37(Suppl 1): S65–136.
17.
K/DOQI Workgroup.K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis2005;45(Suppl 3):S1–153.
18.
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.Am J Kidney Dis2003; 42(Suppl 3):S1–201.
19.
FriedLHutchisonAStegmayrBPrichardSBargmanJM. Recommendations for the treatment of lipid disorders in patients on peritoneal dialysis. ISPD guidelines/recommendations. International Society for Peritoneal Dialysis. Perit Dial Int1999; 19:7–16.
20.
JayanthiV.Vegetarianism in India. Perit Dial Int2001; 21(Suppl 3):S322–5.
21.
PassadakisPSudKDuttaASinghalMPettitJChatalalsinghC. Bioelectrical impedance analysis in the evaluation of the nutritional status of continuous ambulatory peritoneal dialysis patient. Adv Perit Dial1999; 15:147–52.
22.
MushnickRFeinPAMittmanNGoelNChattopadhyayJAvramMM. Relationship of bioelectrical impedance parameters to nutrition and survival in peritoneal dialysis patients. Kidney Int2003; 64(Suppl 87):S53–6.
23.
BrundavaniVNayakKSSinojAMaryBKanchanaDSubramanyamSV. Keto-analogues in CAPD patients. Perit Dial Int2006; 26(Suppl 2):S38.
NakamotoHNishidaERyuzakiMSoneMYoshimotoMItagakiK.Blood pressure monitoring by cellular telephone in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial2004; 20:105–10.
26.
WongHSOngLMLimTOHooiLSMoradZGhazalliR. A randomized, multicenter, open-label trial to determine peritonitis rate, product defect, and technique survival between ANDY-Disc and UltraBag in patients on CAPD. Am J Kidney Dis2006; 48:464–72.
27.
DalyCDCampbellMK. Is it possible for studies comparing Y-set, double bag, and standard systems of CAPD to be blinded?Nephrol Dial Transplant2001; 16:2440–1.
28.
NayakKS. “Biased” comparison between ANDY-Disc and UltraBag in patients on CAPD. Am J Kidney Dis2007; 49:172.
29.
MisraMVoneshEVan StoneJCMooreHLProwantBNolphKD. Effect of cause and time of dropout on the residual GFR: a comparative analysis of the decline of GFR on dialysis. Kidney Int2001; 59:754–63.
30.
SheminDMaazDSt PierreDKahnSIChazanJA. Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. Am J Kidney Dis1999; 34: 14–20.
31.
BakerRJSeniorHClemengerMBrownEA. Empirical aminoglycosides for peritonitis do not affect residual renal function. Am J Kidney Dis2003; 41:670–5.
32.
MahajanSTiwariSC. Analysis of depression and its effects on outcome in adult Indian peritoneal dialysis patients. Perit Dial Int2006; 26(Suppl 2):S97.
33.
LiPKChowKM. The cost barrier to peritoneal dialysis in the developing world—an Asian perspective. Perit Dial Int2001; 21(Suppl 3):S307–13.
34.
HooiLSLimTOGohAWongHSTanCCAhmadG. Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia. Nephrology2005; 10:25–32.
